tirzepatide cv outcomes trial cardiovascular results august 2025 Matches Dulaglutide in Large Trial: SURPASS-CVOT Tirzepatide Improves HFpEF Symptoms and – An Observational Study of Cardiovascular – SURPASS-CVOT Published: Large Trial Confirms

US$ 26.74

★★★★★ 4.5 (26 reviews)

US$ 22.58

★★★★★ 4.6 (27 reviews)

US$ 23.47

★★★★★ 4.8 (24 reviews)

US$ 22.19

★★★★★ 4.0 (14 reviews)

US$ 26.81

★★★★★ 4.4 (20 reviews)

US$ 24.47

★★★★★ 4.5 (5 reviews)

US$ 25.75

★★★★★ 4.3 (8 reviews)

US$ 24.08

★★★★★ 4.9 (29 reviews)

US$ 24.89

★★★★★ 4.6 (28 reviews)

US$ 26.57

★★★★★ 4.9 (21 reviews)

US$ 28.50

★★★★★ 4.4 (29 reviews)

US$ 22.65

★★★★★ 5.0 (14 reviews)

US$ 26.77

★★★★★ 4.5 (5 reviews)

US$ 24.93

★★★★★ 4.4 (16 reviews)

US$ 26.22

★★★★★ 4.5 (17 reviews)

US$ 27.87

★★★★★ 4.4 (24 reviews)

US$ 29.21

★★★★★ 4.7 (27 reviews)

US$ 20.66

★★★★★ 4.1 (6 reviews)

US$ 20.01

★★★★★ 4.1 (24 reviews)

US$ 21.71

★★★★★ 4.5 (27 reviews)